Companies › ZBH
ZIMMER BIOMET HLDGS INC (ZBH)
Institutional ownership, SEC filings and insider activity
Sector: Healthcare & Pharma · SEC CIK 0001136869 · EDGAR filings · Updated 2026-07-23
ZIMMER BIOMET HLDGS INC (ZBH) has reported institutional ownership of 99.4%, with 909 institutional managers holding positions valued at $17.4B per the latest 13F reporting period. The company has 6 bond series in the registry.
Filings this week (1)
- 2026-07-23 — Initial insider ownership filed (Form 3)
Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.
Latest updates
- 2026-07-16 — Notice of proposed sale filed (Form 144)
- 2026-07-02 — Insider transaction reported (Form 4)
- 2026-07-02 — Insider transaction reported (Form 4)
- 2026-07-02 — Insider transaction reported (Form 4)
- 2026-07-02 — Insider transaction reported (Form 4)
- 2026-07-02 — Insider transaction reported (Form 4)
- 2026-07-02 — Insider transaction reported (Form 4)
- 2026-07-02 — Insider transaction reported (Form 4)
Institutional ownership overview
According to SEC 13F filings tracked by Sightfile, ZIMMER BIOMET HLDGS INC has 909 institutional holders and institutional ownership of 99.4%.
| # | Institution | Reported value | % of tracked total |
|---|---|---|---|
| 1 | Dodge & Cox | $2.13B | 12.3% |
| 2 | BlackRock, Inc. | $1.39B | 8.0% |
| 3 | HARRIS ASSOCIATES L P | $1.17B | 6.7% |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | $1.16B | 6.7% |
| 5 | Capital International Investors | $824.6M | 4.7% |
| 6 | STATE STREET CORP | $800.1M | 4.6% |
| 7 | VANGUARD PORTFOLIO MANAGEMENT LLC | $782.2M | 4.5% |
| 8 | PRICE T ROWE ASSOCIATES INC /MD/ | $723.3M | 4.2% |
| 9 | FRANKLIN RESOURCES INC | $493.0M | 2.8% |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | $484.6M | 2.8% |
Full holder history and quarter-over-quarter changes are available inside the app.
Insider activity
Insiders reported 73 transactions (0 buys, 7 sells) across 7 reporting insiders, with a net reported value of −$950.6K.
Quarterly net insider value, as reported in Form 4 filings.
Debt profile
6 active bond series in the registry, coupons ranging 3.52%–5.50%, maturities through 2035, built from the company's own prospectus filings.
Debt maturity schedule
Principal coming due by year for ZIMMER BIOMET HLDGS INC, from the company's own SEC prospectus filings (424B) tracked by Sightfile.
| Year | Bond series maturing | Known principal due |
|---|---|---|
| 2027 | 1 | — |
| 2028 | 1 | $500.0M |
| 2030 | 2 | — |
| 2031 | 1 | — |
| 2032 | 2 | — |
| 2034 | 1 | $700.0M |
| 2035 | 2 | — |
| 2039 | 1 | — |
| 2045 | 1 | — |
Coupons, seniority and prospectus links for each series are available inside the app.
Related companies
ILLUMINA INC (ILMN) · REVOLUTION MEDICINES INC (RVMD) · INCYTE CORP (INCY) · ALCON AG (ALC) · ROYALTY PHARMA PLC CLASS A (RPRX) · MODERNA INC (MRNA)
See full history, cross-references and alerts on SightfileData sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-23.